MT-2 (Melanotan II) – Comprehensive Research Overview (2026)
Melanotan II (MT-2) is a synthetic cyclic analog of α-MSH that acts as a non-selective melanocortin receptor agonist (MC1R, MC3R, MC4R). It is researched for skin tanning, sexual dysfunction, appetite suppression, and metabolic effects. MT-2 is the precursor to PT-141 (Bremelanotide), which was derived from it by removing the lactam bridge. Unlike MT-1, MT-2 has broader receptor activity, producing more pronounced sexual arousal and appetite-suppressing effects alongside tanning.
→ View MT-2 (for laboratory research use only)
Mechanism of Action
- Binds MC1R → melanogenesis and skin tanning.
- Binds MC3R → metabolic effects, appetite modulation.
- Binds MC4R → sexual arousal, erectile function, appetite suppression.
- Broader receptor profile than MT-1 produces more systemic effects.
- Cyclic structure confers greater potency and stability than linear α-MSH.
Clinical Evidence and Research Findings
Early clinical trials demonstrated significant tanning and sexual arousal effects. PT-141 (derived from MT-2) went on to receive FDA approval for HSDD in women. MT-2 itself is not FDA-approved but is widely researched for tanning, erectile dysfunction, and metabolic effects. Its broad receptor profile makes it a versatile but less selective research tool compared to MT-1 or PT-141.
→ Interested in researching MT-2? View Product Options
Benefits (Research & Clinical Observations)
- Skin tanning and photoprotection
- Enhanced sexual arousal and erectile function
- Appetite suppression and potential weight loss effects
- Broad melanocortin system research tool
Typical Dosing Protocols (Research)
- Tanning protocols: 0.25–1 mg subcutaneous daily or every other day (loading), then 0.5–1 mg 1–2× per week (maintenance)
- Sexual function: 0.5–1 mg subcutaneous 1–2 hours before activity
- Start low (0.25 mg) to assess nausea tolerance
Safety Profile and Side Effects
Common side effects: nausea (most common, especially at higher doses), facial flushing, spontaneous erections, yawning, fatigue. Nausea is dose-dependent and typically resolves with lower starting doses. Monitoring of skin lesions recommended with prolonged use.
MT-2 vs MT-1 vs PT-141 – Quick Comparison
| Aspect | MT-2 | MT-1 | PT-141 |
|---|---|---|---|
| Receptors | MC1R, MC3R, MC4R | Primarily MC1R | MC3R, MC4R |
| Tanning | Strong | Strong | Minimal |
| Sexual Effects | Strong | Minimal | Strong (primary use) |
| FDA Status | Not approved | Approved (EPP) | Approved (HSDD) |
Summary
MT-2 is a broad-spectrum melanocortin agonist with potent tanning, sexual arousal, and appetite-suppressing effects. Its multi-receptor activity makes it a versatile but less selective research tool than MT-1 or PT-141. As with all compounds in this library, MT-2 is not an approved drug and should only be considered under qualified medical supervision.
For Laboratory Research Use View MT-2 →
Disclaimer This overview is strictly educational and based on publicly available scientific literature as of April 2026. It does not constitute medical advice. Always consult a qualified healthcare professional and comply with all applicable laws and regulations.